首页> 外文期刊>Nucleic Acids Research >circ-Sirt1 controls NF-B activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132/212 in vascular smooth muscle cells
【24h】

circ-Sirt1 controls NF-B activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132/212 in vascular smooth muscle cells

机译:通过在血管平滑肌细胞中结合miR-132/212,通过序列特异性相互作用和增强SIRT1表达来控制NF-B激活

获取原文
获取原文并翻译 | 示例
           

摘要

NF-B-mediated inflammatory phenotypic switching of vascular smooth muscle cells (VSMCs) plays a central role in atherosclerosis and neointimal formation. However, little is known about the roles of circRNAs in the regulation of NF-B signaling. Here, we identify the involvement of circ-Sirt1 that was one of transcripts of SIRT1 host gene in VSMC inflammatory response and neointimal hyperplasia. First, in the cytoplasm, circ-Sirt1 directly interacts with and sequesters NF-B p65 from nuclear translocation induced by TNF- in a sequence-dependent manner. The inhibitory complex of circ-Sirt1-NF-B p65 is not dependent on IB. Second, circ-Sirt1 binds to miR-132/212 that interferes with SIRT1 mRNA, and facilitates the expression of host gene SIRT1. Increased SIRT1 results in deacetylation and inactivation of the nuclear NF-B p65. These findings illustrate that circ-Sirt1 is a novel non-coding RNA regulator of VSMC phenotype.
机译:NF-B介导的血管平滑肌细胞(VSMC)的炎症表型切换在动脉粥样硬化和新内膜形成中起着重要作用。 然而,关于Circrnas在NF-B信号调节中的角色知之甚少。 在这里,我们识别循环SIRT1的参与,即VSMC炎症反应和新内膜增生中SIRT1宿主基因的转录物之一。 首先,在细胞质中,循环系统1以序列依赖性方式直接与TNF诱导的核转移相互作用并螯合NF-B P65。 循环Sirt1-NF-B P65的抑制络合物不依赖于IB。 其次,循环系统1结合MiR-132/212,其干扰SIRT1 mRNA,并促进宿主基因SIRT1的表达。 增加的SIRT1导致核NF-B P65的脱乙酰化和失活。 这些发现表明Circ-Sirt1是VSMC表型的新型非编码RNA调节剂。

著录项

  • 来源
    《Nucleic Acids Research》 |2019年第7期|共14页
  • 作者单位

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Affiliated Hosp 4 Dept Surg Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Hosp 2 Dept Cardiovasc Med Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Hosp 2 Dept Cardiovasc Med Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Affiliated Hosp 4 Dept Surg Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

    Hebei Med Univ Coll Basic Med Dept Biochem &

    Mol Biol Key Lab Med Biotechnol Hebei Prov Shijiazhuang Hebei Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号